• Skip to main content
  • Skip to navigation
  • Skip to footer

Minnesota Council On Disability

Your Policy, Training and Technical Resource

Search

You are here: Home / Public Policy / Public Policy Agenda Archive / 2021 Legislative Agenda / Out-of-Network Coverage for Diagnosis and Treatment of Rare Diseases

Out-of-Network Coverage for Diagnosis and Treatment of Rare Diseases

2021 Policy Memorandum
Date: 92nd Legislature, 2021 session
Re: Out-of-Network Coverage for Diagnosis & Treatment of Rare Diseases

Summary

2021 Bills: SF 626 (Draheim), HF 626 (Reyer)

Under most Minnesota-based health insurance policies, Minnesotans with rare diseases must first see doctors and specialists within their insurance network before being referred to see an out-of-network specialist. Due to the nature of rare diseases, few doctors may be aware of the disease, much less able to treat the condition. These policies require a person with a rare disease to see many doctors, which can be time-consuming and a financial burden. In many cases, a person with a rare disease knows which specialist they need to see, especially if there are a limited number of specialists who can accurately diagnose and treat the disease. Updating Minnesota law to require health insurance plans to allow people with rare diseases to see specialists right away, regardless if they are in-network or not, would save time and reduce financial burdens.

Disability Context

Many disabilities are manifestations of rare diseases. Rare disease patients often have diagnostic odysseys, waiting for an average of 6 years from the onset of symptoms for an accurate diagnosis. Misdiagnosis and incorrect treatment are frequent in rare diseases. During this odyssey, patients suffer from loss of quality of life, disease progression, incorrect treatment, and sometimes irreversible complications. At the same time, unnecessary consultations cause substantial costs for the individual and healthcare systems. Before a correct diagnosis, patients see an average of 7.3 physicians.

Potential Partners

  • Minnesota Consortium for Citizens with Disabilities
  • Gillette Children’s Specialty Healthcare
  • Rare Disease Advisory Council

Opposition Considerations

Insurance Companies and health plan lobbyists may oppose this bill because of perceived increased costs to insurance companies. However, it is also possible that this could reduce the cost to insurance companies because it reduces the number of hospital and physician visits for the patient. Health insurance cost analysis would be beneficial.

Goal of Policy

Rare diseases cause a wide range of disabilities, so a bill to improve access to diagnosis and treatment of rare diseases would have a significant impact on the quality of life of many Minnesotans with disabilities.

Primary Sidebar

  • COVID-19 Information
  • Blog
  • Events
  • About
    • Our Mission
    • Staff
    • Council
    • More About MCD
  • Public Policy
    • 2022 Public Policy Agenda
    • Additional Public Policy Info
  • Information and Assistance
    • Emergency Preparedness
    • Disability Parking
    • Protect Your Business, Remove Barriers
    • Service Animals
    • Additional Info and Assistance
  • ADA Information
    • Keep Moving Forward
  • Other Resources
    • Alphabetical Resources
    • Resources By Topic
  • Contact Us

Stay Connected

Sign up for the latest MCD news and updates sent to your inbox.

Footer

Find Us

Minnesota Council on Disability (MCD)
1600 University Avenue W, Suite 8
Saint Paul, MN 55104

For accommodation requests, including requesting any document on this website in an alternative format, visit our ADA Title II page.

Contact Us

Phone: 651-361-7800 (VRS)
Toll-free: 1-800-945-8913 (VRS)
Fax: 651-296-5935

Email: council.disability@state.mn.us

Sign up for updates from MCD

Follow Us

Facebook  Twitter  YouTube

Accessibility of Our Site · Site Map
© 2022 · Minnesota Council On Disability. All rights reserved. · Built by Westwords